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NotochordEndocardial cells form the inner endothelial layer of the heart tube, surrounded by the myocardium. Signaling
pathways that regulate endocardial cell speciﬁcation and differentiation are largely unknown and the origin of
endocardial progenitors is still being debated. To study pathways that regulate endocardial differentiation in a
zebraﬁsh model system, we isolated zebraﬁshNFATc1 homolog which is expressed in endocardial but not vas-
cular endothelial cells. We further demonstrate that Hedgehog (Hh) but not VegfA or Notch signaling is re-
quired for early endocardial morphogenesis. Pharmacological inhibition of Hh signaling with cyclopamine
treatment resulted in nearly complete loss of the endocardial marker expression. Simultaneous knockdown
of the two zebraﬁsh sonic hedgehog homologs, shh and twhh or Hh co-receptor smoothened (smo) resulted
in similar defects in endocardial morphogenesis. Inhibition of Hh signaling resulted in the loss of ﬁbronectin
(fn1) expression in the presumptive endocardial progenitors as early as the 10-somite stage which suggests
that Hh signaling is required for the earliest stages of endocardial speciﬁcation. We further show that the en-
doderm plays a critical role in migration but not speciﬁcation or differentiation of the endocardial progenitors
while notochord-derived Hh is a likely source for the speciﬁcation and differentiation signal. Mosaic analysis
using cell transplantation shows that Smo function is required cell-autonomouslywithin endocardial progenitor
cells. Our results argue that Hh provides a critical signal to induce the speciﬁcation and differentiation of endo-
cardial progenitors.
© 2011 Elsevier Inc. All rights reserved.Introduction
Speciﬁcation of endocardium
Theheart is composedof diversemuscle andnon-muscle cell lineages:
atrial/ventricular cardiac myocytes, conduction system cells, smooth
muscle/endothelial cells of the coronary arteries and veins, endocardial
cells, valvular components and connective tissue (Laugwitz et al., 2008).
During cardiogenesis, the differentiation of these multiple heart line-
ages is under tight spatial and temporal control, resulting in the coordi-
nated formation of the distinct tissue components of the heart (Brand,
2003; Harvey, 2002). Although signiﬁcant progress has been made to-
wards elucidating the morphogenetic events and transcriptional con-
trol underlying the patterning of the myocardium, the morphogenetic
events and transcription factors involved in early development of the
endocardium remain largely undeﬁned. In fact, the origins of endocardial
cells are still debated (Harris and Black, 2010; Lough and Sugi, 2000).ital Medical Center, Division of
H 45229, USA.
anas).
rights reserved.Previous studies using largely in vitro cell culturemodels have suggested
that endocardial cells represent a distinct endothelial lineage and have
implicated BMP,Wnt, Gata5 and NFATc1 function in regulating endocar-
dial differentiation (Misfeldt et al., 2009; Nemer and Nemer, 2002).
Vascular endothelial and endocardial cells share expression of multiple
markers including cdh5, ﬂi1, kdrl and tie2 (Brown et al., 2000; Larson et
al., 2004; Lyons et al., 1998; Sumanas et al., 2005; Thompson et al.,
1998). Very few knownmolecular markers are speciﬁc to endocardium;
one of them is nuclear factor of activated T-cells, cytoplasmic, calcineurin-
dependent 1 (NFATc1), which is expressed in the mouse endocardial
but not vascular endothelial cells indicating that the two endothelial sub-
types are biochemically distinct (de la Pompa et al., 1998).
Zebraﬁsh has emerged as an advantageous model system for early
development and cardiac speciﬁcation. Similar to other vertebrates,
zebraﬁsh endocardial and myocardial precursors originate in the bi-
lateral adjacent regions within the anterior lateral plate mesoderm
(ALPM) during the early somitogenesis stages. Based on fate mapping
experiments in zebraﬁsh, the rostral ALPM region, in addition to the
endocardial progenitors, also gives rise to the vascular endothelial
and myeloid cells (Schoenebeck et al., 2007). While NFATc homologs
have not been previously characterized in zebraﬁsh, early endocardial
precursors can be observed by analyzing the expression of vascular
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both endocardial and endothelial cell populations. Endocardial pre-
cursors can be distinguished from other vascular endothelial cells as
they migrate towards the midline and posteriorly and fuse between
the 15–18 somite stages (Bussmann et al., 2007). Subsequently,
they undergo a complex leftward movement to position endocardial
primordium at the left side of the embryo between the 22–26 somite
stages. At this point, endocardial cells become positioned next to the
myocardial precursors and form the lining of the primitive heart tube.
Signaling pathways involved in any of these steps during endocardium
formation in vivo are currently largely unknown.
Endoderm has been previously implicated in cardiac induction
(Lough and Sugi, 2000). Zebraﬁsh endodermal mutants such as cas/
sox32 display cardiac biﬁda as myocardial precursors remain posi-
tioned bilaterally and fail to migrate to the midline (Alexander et
al., 1999; Kupperman et al., 2000). Kdrl and ﬂi1-expressing presump-
tive endocardial precursors remain positioned bilaterally and do not
migrate towards the midline in cas mutant embryos (Holtzman et
al., 2007). However, the molecular nature of the endodermal derived
signal is not known. It is also unclear if endoderm plays a direct role in
initiating the migration of endocardial precursors and if it is also re-
quired for their differentiation.
Fibronectin (fn1) is thought to be one of the earliest markers for
endocardial precursors in mammalian embryos and zebraﬁsh
(Palencia-Desai et al., 2011; Suzuki et al., 1995; Trinh and Stainier,
2004). Natter/fn1 homozygous mutant zebraﬁsh embryos display de-
fects in cardiac fusion and defects in the endocardial sheet formation
(Garavito-Aguilar et al., 2010; Trinh and Stainier, 2004). Its function is
required for the migration of myocardial precursors in zebraﬁsh. In
mouse, Fn mutants display multiple defects in cardiac formation al-
though the initial endocardial speciﬁcation appears to proceed nor-
mally (George et al., 1997). However, it is not known whether Fn
function is required for endocardial differentiation.
Vegf, Hh and Notch signaling pathways have been previously impli-
cated inmultiple aspects of endothelial cell differentiation including en-
dothelial progenitor migration, vessel branching and arterial-venous
differentiation (Ellertsdottir et al., 2010). However, their role in endo-
cardial speciﬁcation and differentiation has not been previously ana-
lyzed. Hh signaling, in particular, has been implicated in multiple
processes during development. Followingmodiﬁcationwith cholesterol
and palmitate (Mann and Beachy, 2004), Hh ligands are released from
the producing cells. Hh ligands form amorphogen gradient and the sig-
nal is transduced by the receptor Patched (Ptc) and co-receptor
Smoothened (Smo) (Cohen, 2003; Nagase et al., 2007). Hh binding to
Ptc relieves Ptc-mediated repression of Smo leading to activation of
downstream Gli transcription factors in vertebrates. The steroidal alka-
loid cyclopamine (CyA) is a natural antagonist of Hh signaling by
inﬂuencing the balance between the active and inactive forms of the
Smo protein (Chen et al., 2002). In vertebrates there are three homo-
logues of Drosophila Hh, Sonic Hedgehog (Shh), Indian Hedgehog
(Ihh) and Desert Hedgehog (Dhh). Due to partial genome duplication
in zebraﬁsh, there are two homologs for Shh (Shh and Tiggy-winkle
Hedgehog, Twhh) and Ihh (Ihha and Echidna Hedgehog, Ehh/Ihhb)
(Avaron et al., 2006; Currie and Ingham, 1996; Ekker et al., 1995;
Krauss et al., 1993). Shh expression pattern during early zebraﬁsh de-
velopment includes the notochord, the ﬂoor plate and the endoderm
while twhh expression is restricted to the ﬂoor plate (Ekker et al.,
1995; Reichenbach et al., 2008). Ehh/Ihhb expression is restricted to
the notochord (Currie and Ingham, 1996) while Ihha and Dhh ex-
pression has been reported only in the cartilage precursors (Avaron
et al., 2006).
Hh signaling has been previously implicated in both vascular and
cardiac development in multiple vertebrate systems. In mouse, loss
of Shh causes several cardiac abnormalities, including ventricular hy-
poplasia, septation defects and outﬂow tract shortening (Chiang et al.,
1996; Tsukui et al., 1999). Smo−/−mutant mice exhibit more severecardiac defects, including aberrant cardiac morphogenesis, reduced
heart size and delayed initiation of the early myocardial marker
nkx2.5 expression (Zhang et al., 2001). Vasculature of Ihh or Smo mu-
tant murine yolk sacs fails to develop beyond a primitive vascular
plexus and does not progress up to the angiogenic stage of develop-
ment (Byrd et al., 2002). Zebraﬁsh Smo mutant embryos and
cyclopamine-treated embryos do not form dorsal aorta and display
inhibited migration and arterial differentiation of endothelial cells
(Gering and Patient, 2005; Lawson et al., 2002; Williams et al.,
2010). Recent studies show that Hh signaling is received cell-
autonomously within the endothelial cell progenitors during arterial
differentiation (Williams et al., 2010). Hh signaling has been also im-
plicated in zebraﬁsh myocardial formation since cyclopamine-treated
embryos and Smo mutants have reduced number of cardiomyocytes
(Thomas et al., 2008). However, the role of Hh signaling in the forma-
tion of endocardium if any, remains unknown.
In this studywe analyze themolecular pathways that regulate endo-
cardium formation in zebraﬁsh. We show that Hh signaling is essential
for the endocardial progenitor speciﬁcation and differentiation while
VegfA and Notch function is dispensable for these processes. Genetic
or pharmacological inhibition of Smo or Shh and Twhh function results
in the nearly complete absence of endocardial progenitors while vascu-
lar endothelial differentiation is not affected. We further show that the
endoderm is required for endocardial migration but not differentiation
while the notochord is a likely source of the endocardial speciﬁcation
and differentiation signal which is received cell-autonomously by endo-
cardial cells. These results argue that Hh signal is necessary for speciﬁ-
cation and differentiation of the endocardial progenitors.
Materials and methods
Zebraﬁsh strains and staging
Wild-type Ekkwill (EK) strain and fn1tl43c (AB) (natter) (Jiang et al.,
1996; Trinh and Stainier, 2004), shhat4 (AB) (sonic you) (Schauerte et
al., 1998), smob641 (AB) (Barresi et al., 2000); clom39 (Stainier et al.,
1995); ﬂhn1 (Talbot et al., 1995); mutant strains as well as Tg(ﬂi1a:
EGFP)y1 (Lawson and Weinstein, 2002), Tg(cmlc2:mCherry)sd7
(Palencia-Desai et al., 2011), Tg(etsrp:EGFP)ci1 (Proulx et al., 2010)
transgenic strainwere used in this study. All embryonic stages were de-
termined based on the morphological staging criteria (Kimmel et al.,
1995).
Chemical treatments
Cyclopamine (LC Laboratories) and N-[N-(3,5-Diﬂuorophenacetyl)-
L-alanyl]-S-phenylglycine t-butyl ester (DAPT) (Sigma) was dissolved
at a stock concentration of 10 mM in dimethylsulfoxide (DMSO). Em-
bryos were manually dechorionated in 1× Danieau solution
(Nasevicius and Ekker, 2000) and placed into 100 μM of cyclopamine
or 100 μM DAPT solution. To remove cyclopamine, embryos were
washed 3 times in 1× Danieau solution.
In situ hybridization and overexpression constructs
In situ hybridization was performed as previously described
(Jowett, 1999). NFATc1 (Open Biosystems, cat no. EDR1052-
9118306, accession no. CN320837) and fn1 (Open Biosystems, cat.
no. EDR1052-96834665) cDNA clones, both in pExpress1 vector,
were digested with EcoRI and transcribed with T7 RNA polymerase
(Promega). ﬂk1/kdrl (Thompson et al., 1998); ﬂi1 (Thompson et al.,
1998); cdh5 (Sumanas et al., 2005); ptc1 (Concordet et al., 1996)
probes were synthesized as described. To overexpress shh and twhh
RNA, shh-T7TS and twhh-T7TS constructs (Ekker et al., 1995) were
linearized with BamHI and transcribed using T7 mMessage
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twhh RNA were injected per embryo.
Morpholinos
The following doses of MOs were used for injection: 7.4 ng shh MO
(Nasevicius and Ekker, 2000) (GCAGCACTCTCGTCAAAAGCCGCAT,
Open Biosystems)+2.2 ng p53 MO (Robu et al., 2007); 7.5 ng shh
MO+2 ng twhh MO (GCTTCAGATGCAGCCTTACGTCCAT, Open Bio-
systems)+1 ng p53MO; 10 ng smoMO1 (CGCTTGGAGGACATCTTGGA
GACGC, Open Biosystems)+3.2 smo MO2 (TGTTTCATCAAATGTTTCCA
AATAA, Gene Tools)+2 ng p53 MO; 7.5 ng sox32 MO (Dickmeis et al.,
2001) (CAGGGAGCATCCGGTCGAGATACAT, Gene Tools)+3 ng p53
MO; 10.5 ng VegfA MO (Nasevicius et al., 2000). p53 MO was added
to most MO mixtures to reduce toxic effects (Robu et al., 2007). 3 ng
of standard control MO (CCTCTTACCTCAGTTACAATTTATA, Gene
Tools) and 3 ng of p53 MO were injected in control experiments.
Image capture and processing
For ﬂat-mounting, yolk was manually removed and dehydrated
embryos were ﬂat-mounted in Araldite media. Alternatively, embryos
were whole-mounted in 2% methylcellulose. 22 hpf and older embryos
were mounted on glass slides in 2% methylcellulose. Images were cap-
tured using 5× or 10× objective on AxioImager Z1 (Zeiss) compound
microscopewith Axiocam ICC3 color camera (Zeiss). Images in different
focal planeswere combined using Extended Focusmodulewithin Axio-
vision software (Zeiss). Image levels were adjusted using Adobe Photo-
shop CS2 to increase the contrast.
Real-time RT-PCR analysis
Batches of 25 control uninjected and shh RNA-injected embryos
were frozen on dry ice at 24 hpf stage. Total RNA was puriﬁed using
the RNAquous-4PCR kit (Ambion). cDNA was synthesized using Su-
perscript III reverse transcriptase and oligo-dT primer (Invitrogen).
Real-time PCR was performed using Chromo4 thermal cycler (Bio-
Rad) and iQ SYBR Green Supermix (Bio-Rad). The following PCR pro-
ﬁle was used: 95 °C 5 min; 95 °C 1 min, 58 °C 1 min, 72 °C 1 min, de-
tection at 82 °C for 10 s; steps 2 through 5 repeated 44 times. Primer
sequences used: NFATc1: GTGACGGAGGACAGTTGGTT; AGAGCAGGC
AGTGATGGACT; EF1α: TCACCCTGGGAGTGAAACAGC; ACTTGCAGGCG
ATGTGAGCAG. Relative cDNA amounts were calculated using the iCy-
cler software (BioRad) and normalized to the expression of elongation
factor 1α (EF1α).
Proliferation and apoptosis assays
Whole mount immunohistochemistry against phosphorylated his-
tone H3 was performed as described previously (Shepard et al.,
2004). To perform anti-caspase staining, cyclopamine treated or con-
trol embryos were lightly ﬁxed using 1% paraformaldehyde in 1× PBS
for 1 h. Embryos were rinsed with PBS/0.2% Saponin and blocked with
blocking solution (10% Sheep Serum/2 mg/ml BSA/0.2% (w/v) sapo-
nin in 1× PBS) for 1 h. Embryos were incubated overnight with rabbit
anti-active caspase-3 (BD Pharmingen 559565) antibody (1:400) in
blocking solution, brieﬂy washed with PBS/0.2% Saponin and incubated
in dark for 2 h with 1:400 secondary donkey anti rabbit igG-Alexa 594
(Invitrogen A21207). Secondary waswashed off with PBS/0.2% Saponin
and embryos were immediately ﬂat mounted with Vector Vectashield
(H-1000).
Transplantation
Donor Tg(ﬂi1a:EGFP)y1 embryos were injected with smoMO mix-
ture containing 1 mg/ml Tetramethyl Rhodamine Iso-Thiocyanate(TRITC)-dextran, Mw 2×106 (Invitrogen). Control donor Tg(ﬂi1a:
EGFP)y1 embryos were injected with 15 ng of random control MO
(Gene Tools) and TRITC-dextran. Donor and wt recipient embryos
were manually dechorionated. Approximately 100 cells were trans-
planted from control to recipient embryos by adjusting balance pres-
sure of air pressure microinjector PLI-90 (Harvard Apparatus).
Embryos were analyzed at 30–32 hpf for the presence and location
of ﬂi1a:EGFP ﬂuorescent cells.
Results
NFATc1 expression speciﬁcally labels endocardium
At present, there are very few molecular markers known that are
speciﬁcally expressed in endocardial progenitors during early stages
of differentiation. One of them is NFATc1, expressed in endocardial
but not vascular endothelial cells during early mouse development
(de la Pompa et al., 1998). To determine the expression of zebraﬁsh
NFATc1, we performed in situ hybridization analysis at different
stages of early development using cDNA clone that corresponds to
zebraﬁsh NFATc1 homolog. Its earliest endocardial expression is ap-
parent by 22 hpf and becomes more pronounced by 24–26 hpf
(Figs. 1A–C). Strong NFATc1 expression is also apparent in the olfacto-
ry placodes while much fainter subepidermal expression is present
bilaterally along the trunk, in the adaxial cells along the midline, in
the most caudal part of the notochord and the tailbud (Fig. 1B).
Faint NFATc1 expression is also present within cranial vascular endo-
thelial cells at 22 hpf (Fig. 1A). NFATc1 expression is absent from the
heart region in the cloche mutants which have no endocardium
(Stainier et al., 1995) (Figs. 1C,D), which conﬁrms that NFATc1 ex-
pression is indeed endocardial. NFATc1 expression is present through-
out the endocardium at 32–48 hpf (Figs. 1E,F) while its expression in
vascular endothelial cells is no longer apparent at these stages. By
72 hpf NFATc1 endocardial expression becomes restricted to the
valve forming regions within the atrioventricular canal and the out-
ﬂow tract (Figs. 1G,H). Its intense expression is also apparent in the
olfactory placodes, and the cartilage of pharyngeal arches (Fig. 1G).
Vegf and Notch signaling is dispensable for endocardial differentiation
Vegf, Hh and Notch signaling pathways have been previously im-
plicated in different aspects of endothelial cell differentiation
(Lawson et al., 2001, 2002; Williams et al., 2010). However, their
role in endocardial speciﬁcation and differentiation has not been an-
alyzed. To test if Vegf signaling is required for endocardium forma-
tion, endocardial NFATc1, cdh5, kdrl and ﬂi1 expression was
analyzed at the 18-somite-24 hpf stages in VegfA MO knockdown
embryos. No signiﬁcant defects in endocardial marker expression
were observed in VegfA morphants compared to their uninjected
controls (Figs. S1A–F, Table S1 and data not shown) while arterial
marker expression was absent (Figs. S1G,H), as reported previously
(Lawson et al., 2002). Similarly, pharmacological inhibition of Notch
signaling using γ-secretase inhibitor DAPT had no signiﬁcant effect
on the migration or differentiation of endocardial precursors (Figs.
S2A–D, Table S2), while it resulted in the expansion of venous ﬂt4 ex-
pression and defects in somitogenesis (Figs. S2E,F, and data not
shown), as reported previously (Geling et al., 2002; Lawson et al.,
2001).
Pharmacological inhibition of Hh signaling results in the absence of
differentiated endocardium
To assay the role of Hh signaling in endocardial development, em-
bryos were incubated in 100 μM cyclopamine solution starting at the
sphere stage (4 hpf, see Materials and methods). Subsequently,
Fig. 1. NFATc1 is expressed in the endocardial cells as analyzed by whole-mount in situ hybridization at 22–72 hpf. Dorsal view of ﬂat-mounted embryos, anterior is to the top ex-
cept as noted. (A) NFATc1 is expressed in the endocardial progenitors (end) and the olfactory placodes (op) at 22 hpf. Much fainter expression is also apparent in the cranial en-
dothelial cells. (B) NFATc1 expression at 24 hpf includes olfactory placodes (op), bilateral subepidermal cells along the trunk (arrowheads), adaxial cells along the midline (dotted
arrow), the most caudal part of the notochord and the tailbud (arrow). Lateral (the main panel) and dorsal views of the trunk and tail regions (inset). Endocardial expression is not
apparent in these views. (C,D) Endocardial NFATc1 expression (arrow, C) is absent in clo−/−mutants (D) compared with their siblings in (C) as analyzed at 26 hpf. Approximately
¼ (16 out of 63) embryos obtained from heterozygous clo+/− carriers showed this phenotype. (E,F) NFATc1 expression throughout the endocardium at 32 hpf (E) and 48 hpf (F) (a,
atrium; v, ventricle; arrow points to the atrioventricular boundary). (G,H) NFATc1 expression at 72 hpf includes the olfactory placodes (op) and pharyngeal arch skeleton (pa). NFATc1
is no longer expressed throughout the endocardium but is localized to the valve-forming regions in the atrioventricular canal (arrow, H) and the outﬂow tract (arrowhead, H).
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Endocardial precursors in wild-type (wt) embryos migrate to the
midline during the 15–16-somite stages while vascular endothelial
precursors of the cranial vessels remain bilateral (Bussmann et al.,
2007). Kdrl and chd5 expression at the midline was greatly reduced
in CyA-treated embryos at the 18-somite stage while bilateral expres-
sion of the twomarkers was not affected (Figs. 2A–D, Table S3). Endo-
cardial kdrl and NFATc1 expression within the heart tube was absent
or greatly reduced in CyA-treated embryos at 24–48 hpf stages
(Figs. 2E–J, Table S3). As reported previously, CyA-treated embryos
also display reduced myocardial cmlc2 expression (Figs. 2K,L)
(Thomas et al., 2008). Interestingly, by 48 hpf CyA-treated embryos
have a reduced heart that fails to loop (Thomas et al., 2008). Reduced
endocardium is present in the hearts of CyA-treated embryos at
48 hpf, as observed in endocardial-speciﬁc Tg(etsrp:EGFP)ci1 and
myocardial-speciﬁc Tg(cmlc2:mCherry)sd7 lines (Figs. S3A,B). How-
ever, no NFATc1 expression is observed when the same transgenic
embryos are assayed for its expression by in situ hybridization (Figs.
S3C,D). These experiments argue that Hh signaling is required forthe differentiation of endocardial progenitors as assayed by NFATc1
expression.Shh, twhh and smo function is required for endocardium formation
We tested if genetic inhibition of Hh signaling would also result in
similar defects in endocardium formation. Injection of a previously
validated mixture of shh and twhh MOs (Nasevicius and Ekker,
2000) resulted in a similar absence or strong reduction of endocardial
kdrl and NFATc1 and myocardial cmlc2 expression (Figs. 3A–H, Table
S4). Similarly,MOknockdownof Hh co-receptor Smo resulted in similar
endocardial andmyocardial defects, as analyzed by kdrl and NFATc1 ex-
pression (Figs. 3I–P, Table S4). Because injection of either shh+twhh
MO mixture or smo MO resulted in minor non-speciﬁc defects (data
not shown), p53 MO was added to each MO mixture to prevent non-
speciﬁc activation of p53-mediated apoptosis pathway, commonly acti-
vated byMO injections, as described previously (Robu et al., 2007). Both
shh+p53 MOs and smo+p53 MOs phenocopied previously described
morphological shh−/− and smo−/− zygotic mutant phenotypes
Fig. 2. Endocardial and myocardial markers are reduced or absent in cyclopamine (CyA) treated embryos compared to dimethylsulfoxide (DMSO)-treated controls. (A–D) Kdrl (A,B)
and cdh5 (C,D)-expression within endocardial progenitors that migrate to the midline (arrow) is greatly reduced in CyA-treated embryos (B,D) compared to controls (A,C) at the
18-somite stage. Dorsal view of the anterior region, anterior is up. (E–J) Endocardial kdrl (E,F) and NFATc1 (G-J) expression (arrows) is greatly reduced or absent in CyA-treated
embryos (F,H,J) compared to controls (E,G,I) at the 24 h (E–H) and 48 h (I,J) stages. (K,L) Myocardial cmlc2 expression (arrows) is reduced in CyA-treated embryos at the 18-
somite stage. (E–L) Ventral view of deyolked ﬂat-mounted embryos, anterior is up.
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served at the doses used. Standard control MO or p53 MO injection
resulted in no apparent morphological defects and did not affect endo-
cardial or myocardial development (Figs. S4, S5). NFATc1 expression
was downregulated but still apparent in smo−/− zygotic mutant em-
bryos (Figs. 3Q,R, Table S5). It has been reported that smo displays
strong maternal expression (Chen et al., 2001), which is a likely reason
why smo zygotic mutant phenotype is less severe thanMO knockdown.
Mild reduction of endocardial NFATc1 expression was also observed in
shh−/− mutant embryos (Figs. 3S,T, Table S5). The phenotype is not
as severe as with the double shh/twhh MO injection likely because of
partially redundant role between shh and twhh homologs in endocardi-
um formation.
Hh signaling is required between 10 hpf and 16.5 hpf stages for endocar-
dial morphogenesis
To determine the temporal window for Hh requirement in endo-
cardium formation, cyclopamine was added or removed at different
stages of development. Addition of cyclopamine at the 10-somite
stage (14 hpf) or earlier resulted in the majority of embryos showing
nearly complete loss of endocardial NFATc1 and kdrl expression
(Figs. 4A,C). However, treatment at the 15-somite stage (16.5 hpf)
resulted in the majority of embryos showing still signiﬁcant but less
severe reduction in NFATc1 expression (Figs. 4A,C, Table S6). Interest-
ingly, these embryos only showed minor reduction in kdrl expression
which suggests that Hh signaling is required at later stages for endo-
cardial differentiation (NFATc1 expression) than speciﬁcation (kdrl
expression). Most of the embryos treated at the 20-somite stage
(19 hpf) and later displayed mild or no reduction in NFATc1 or kdrl
expression (Figs. 4A,C, Table S6). These data indicate that Hh signal-
ing is required until the 15-somite (16.5 hpf) stage while at later
stages it only plays minor if any role in endocardial morphogenesis.
To determine the starting point for Hh signaling requirement, em-
bryos were treated with CyA starting at the sphere stage (4 hpf) and
CyA was washed out at different developmental stages. CyA removal
1–1.5 h later at the 30–50% epiboly stages resulted in no signiﬁcant
defects in endocardium formation which demonstrates that CyA canbe effectively removed with this method (Fig. 4B). Embryos that
were removed from CyA solution at the tailbud stage (10 hpf)
showed a signiﬁcant reduction in NFATc1 and kdrl expression while
removal at the 5-somite stage (11.5 hpf) and later resulted in strong
reduction or nearly complete loss of the endocardial staining
(Figs. 4B,D, Table S7). These data argue that Hh signaling is required
from the tailbud until the 15-somite stages (10–16.5 hpf) for endo-
cardial morphogenesis. In a control experiment, CyA-treatment effec-
tively inhibited expression of Hh target gene ptc1, and CyA could be
efﬁciently washed out after incubating embryos for 1.5 h in the CyA
solution (Figs. S6A–C). Furthermore, incubation for only 2.5 h in CyA
solution from the 19-somite to the 25-somite stages was sufﬁcient
to effectively inhibit ptc1 expression (Figs. S6D–F).
Previous studies have demonstrated Hh requirement for myocar-
dial morphogenesis (Thomas et al., 2008). It is possible that Hh sig-
naling is required independently for both myocardial and
endocardial morphogenesis or, alternatively, observed endocardial
defects may be a secondary consequence due to perturbed myocardial
morphogenesis. Previous studies have deﬁned the temporal window
for Hh requirement in myocardial morphogenesis, between the germ
ring and the 10-somite stage (Thomas et al., 2008).We tested if treating
at a later stage may selectively affect endocardial morphogenesis. In-
deed, CyA addition at the 15-somite stage resulted in signiﬁcant inhibi-
tion of endocardial NFATc1 expression but had little if any effect on
myocardial cmlc2 expression (Fig. 5, Table S8). These results argue
that Hh signaling has independent roles in endocardial and myocardial
morphogenesis.
Hh overexpression perturbs endocardial morphogenesis
To test if Hh signaling is sufﬁcient for endocardial speciﬁcation,
synthetic shh or twhh RNA was microinjected into zebraﬁsh embryos.
Overexpression of either shh or twhh RNA resulted in speciﬁc defects
that included reduction or loss of lens and retinal fates, as reported
previously (data not shown) (Ekker et al., 1995). NFATc1-expressing
endocardial precursors in shh or twhh RNA injected embryos were
present in the wide area in the cardiac forming region close to the
midline but did not coalesce into the cardiac tube (Fig. 6). Based on
Fig. 3. Endocardial and myocardial markers are reduced in shh+ twhh and smoMO knockdown and mutant embryos. Ventral view of the anterior region in ﬂat-mounted embryos
except as noted; anterior is to the top. (A–H) Injection of a mixture of shha and twhh/shhb MOs resulted in strong downregulation of endocardial kdrl (A,B,E,F), NFATc1 (G,H)
(arrows) and myocardial cmlc2 (C,D) expression. (I–P) Smo MO injection results in the reduction or absence of kdrl-expressing endocardial progenitors at the midline at the 18-
somite stage (arrows, I,J), the absence of endocardial kdrl (arrows, M,N) and NFATc1 expression at 26 hpf (arrows, O,P) and reduction of myocardial cmlc2 expression at the 20-
somite stage (K,L). (Q–T) Smo−/− (R) and shha−/− (T) genetic mutant embryos display reduced endocardial NFATc1 expression (arrows) compared to their siblings (Q,S).
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RNA injected embryos was not signiﬁcantly different from uninjected
controls (shh RNA vs. control ratio was 0.79±0.16 for 50 pg shh RNAdose and 1.12±0.17 for 150 pg). This shows that Hh overexpression
perturbs endocardial morphogenesis but is not sufﬁcient to induce
ectopic endocardial differentiation.
Fig. 4. Hedgehog signaling is required during 10–16.5 hpf period for endocardial differentiation based on NFATc1 expression analysis at 26 hpf. Flat-mounted embryos, dorsal view,
anterior is to the top. (A) Cyclopamine addition at different stages of development shows that Hh signaling is required at least until approximately 16.5 hpf for endocardial NFATc1
and kdrl expression (arrows) while treatment after 19 hpf has little effect on the endocardium formation. Left panels, control embryos incubated in DMSO. Note the absence of en-
docardial tube in the embryos treated starting at 4 and 14 hpf. (B) Cyclopamine removal at different stages of development shows that Hh signaling is required from 10 hpf for
endocardial NFATc1 and kdrl expression (arrows). Numbers indicate the treatment interval. (C,D) Percentage of embryos that display signiﬁcant NFATc1 (blue bars) and kdrl
(red bars) reduction (more than 50% of expression area is affected) at different stages of cyclopamine addition (C) and removal (D).
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Fig. 5. CyA treatment at the 15-somite stage selectively affects endocardial NFATc1 but
not myocardial cmlc2 expression. Embryos were treated in CyA solution starting from
the 15-somite stage until 25 hpf and analyzed at 25 hpf stage. Ventral view of ﬂat-
mounted embryos, anterior is to the top.
Fig. 6. Overexpression of Hh results in a failure of endocardial progenitors to coalesce into
jected embryo, (B,C) shh and (D–F) twhh RNA injected embryos.
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Fibronectin (fn1) is an extracellular matrix protein, necessary for
the migration of cardiomyocytes. It is thought to be secreted by the
endocardial cells in both mammalian and zebraﬁsh embryos and is
the earliest currently known marker expressed in the endocardial
but not vascular-endothelial progenitors (George et al., 1997;
Palencia-Desai et al., 2011; Suzuki et al., 1995; Trinh and Stainier,
2004). Its expression was greatly reduced in CyA-treated embryos
as early as the 10-somite stage, well before the migration of endocar-
dial precursors to the midline (Figs. 7A,B, Table S9). Similar reduction
in fn1 expression was also observed at the 14-somite and 18-somite
stages (Figs. 7C–F). Fn1 expression was also reduced in shh+ twhh
MO and smo MO-injected embryos (Figs. 7G–J, Table S9). These re-
sults argue that Hh signaling affects endocardial fn1 expression as
early as the 10-somite stage, suggesting that Hh is involved in the ear-
liest stages of endocardial speciﬁcation.
Because the loss of fn1 expression in the endocardial precursors is
the earliest endocardial defect observed in CyA-treated embryos, we
considered a possibility that the absence of fn1 function may be re-
sponsible for the later defects in endocardial morphogenesis. Howev-
er, as reported in a recent study, endocardial progenitors do migrate
to the midline in the natter/fn1 genetic mutants where they form a
dismorphic sheet (Garavito-Aguilar et al., 2010) (Figs. 7K,L). Interest-
ingly, NFATc1 expression was nearly completely absent in nat mu-
tants while kdrl expression appeared to label a severely reduced
heart tube that is mislocalized and forms abnormal vascular connec-
tions (Figs. 7M–P, Table S5). Fn1 expression was nearly completely
absent in nat mutants which prevented us from analyzing the pres-
ence and location of fn1-expressing progenitors (data not shown).
Therefore while fn1−/− mutants and CyA-treated embryos sharethe heart tube (arrows) as analyzed by NFATc1 expression at 26 hpf. (A) Control unin-
Fig. 7.Hh signaling is required for the initiation of ﬁbronectin (fn1) expression in the ALPM region while fn1 function is required for endocardial differentiation. (A–F) Fn1 expression
in the endocardial progenitors (arrows) is reduced in CyA-treated embryos (B,D,F) compared to DMSO-treated controls (A,C,E) at the 10-somite (A,B), 14-somite (C,D) and 18-
somite (E,F) stages. (G–J) Fn1 expression is absent from the endocardial progenitors in smoMO (H) and shh+ twhhMOmixture (J) -injected embryos as compared with uninjected
controls (G,I) at the 16-somite stage. (K–P) Analysis of endocardial markers in nat/fn1−/− mutant embryos. (K,L) Endocardial kdrl expression is present at the midline in nat/fn1
homozygous mutant embryos (L), similar to their wild-type siblings at the 18-somite stage (K). (M,N) Endocardial NFATc1 expression is absent in fn1/nat mutants at 36 hpf. (O,P)
Endocardial kdrl expression appears to be mislocalized and reduced in fn1/nat mutants at 32 hpf. Note that while the arrow points to the presumptive endocardial tube in nat mu-
tants (P), it is not possible to reliably distinguish endocardial from vascular endothelial cells based on kdrl expression alone. All panels, ventral view of ﬂat-mounted embryos, an-
terior is up. Individual nat mutant embryos were genotyped at the 18-somite stage following in situ hybridization as described previously (Garavito-Aguilar et al., 2010), while at
older stages they were separated based on their morphological phenotypes.
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tinct, and the loss of endocardial fn1 expression cannot fully account
for all of the endocardial defects observed in Hh-inhibited embryos.
Time-lapse imaging of endocardial precursor migration in Hh-inhibited
embryos
In an attempt to determine the fate of the endocardial precursors
in CyA-treated embryos, we performed time-lapse imaging in Tg
(etsrp:EGFP)ci1 transgenic line. While there is currently no reporter
line which would label exclusively endocardial progenitors at these
early stages, Tg(etsrp:EGFP) is one of the earliest reporters which dis-
plays strong expression in the endocardial progenitors, as well asvascular endothelial and myeloid cells which all originate in the
ALPM region (Proulx et al., 2010). As we and others have reported
previously, endocardial progenitors originate in the midbrain-
organizing center (MOC) within the ALPM, which also gives rise to
the cranial vascular endothelial and myeloid progenitors (Proulx et
al., 2010; Schoenebeck et al., 2007). Since it was not possible to
image CyA-treated embryos under standard treatment conditions, be-
cause embryos had to be removed and mounted in the agarose for ex-
tended time periods, during which they showed signiﬁcant recovery
of endocardial defects, we imaged CyA-treated embryos that were
injected with Smo MO. This “double” inhibition of Hh signaling
resulted in reproducible defects in endocardial morphogenesis, simi-
lar to the ones observed under standard CyA-treated conditions. No
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proceeded normally in Hh-inhibited embryos and no apparent de-
fects were observed at the 10–12-somite stages (Fig. S7, 0 min,
Suppl. Movies 1, 2). We have also quantiﬁed Tg(etsrp:EGFP)-expres-
sing cells in the MOC region in ﬁxed ﬂat-mounted embryos, and
there was no signiﬁcant difference between the Hh-inhibited and
control embryos (Table S10). However, as the endocardial cells mi-
grated towards the midline in wt embryos at the 14–15-somite
stages, such migration was notably absent in Hh-inhibited embryos
(Fig. S7, 80–120 min). Quantiﬁcation of Tg(etsrp:EGFP) cells in
DMSO control and CyA-treated embryos at the 16–17-somite stages
showed that the midline population of GFP cells was signiﬁcantly re-
duced while the numbers of bilaterally located cells that normally
correspond to the cranial endothelial progenitors were not affected
(Table S10). Interestingly, the total number of GFP positive cells was
smaller in Hh-inhibited embryos suggesting either defective cellFig. 8. Proliferation of endocardial progenitors is reduced in CyA-treated embryos compared
(left), phospho-histone staining (right) and overlap of the two channels (middle) are shown
top. Formation of the midbrain-organizing center (MOC, arrows) which gives rise to many
CyA-treated embryos. However, phospho-histone staining within the MOC region (arrowhe
view is the maximum projection image, staining in some cells may appear to overlap while
per embryo of phospho-histone stained Tg(etsrp:EGFP) cells in the MOC region which is s
graph, the number of neural progenitors scored in a randomly selected area is not signiﬁcaproliferation, speciﬁcation or increased apoptosis among endocardial
progenitors.
Hh signaling promotes proliferation of endocardial progenitors
To determine if Hh signaling may regulate proliferation of endocar-
dial progenitors, we performed immunostaining against phospho-
Histone H3 in etsrp:GFP transgenic CyA-treated and control DMSO-
treated embryos. Z-stacks of ﬂat-mounted embryos were analyzed for
an overlap of GFP ﬂuorescence and phospho-H3 immunostaining in
each section within the MOC region at the 12–13-somite stages. A sig-
niﬁcant reduction in proliferating Tg(etsrp:EGFP) cells within the MOC
region was observed in CyA-treated embryos (Fig. 8). DMSO treated
embryos had an average of 5.5 proliferating cells per embryo while
CyA-treated embryos had only 2.5 (p=0.01).We also assessed cell pro-
liferation in the neural region which was not affected in CyA-treatedto DMSO-treated controls. Maximum projection images of Tg(etsrp:EGFP) ﬂuorescence
. Ventral views of ﬂattened deyolked embryos at the 13-somite stage, anterior is to the
cranial endothelial, endocardial and myeloid progenitors is not signiﬁcantly affected in
ads) is signiﬁcantly reduced in CyA-treated embryos. Note that because the presented
they are actually present in different focal planes. Left graph shows average cell count
igniﬁcantly different between DMSO and CyA-treated embryos. As shown in the right
ntly different between the DMSO and CyA-treated embryos.
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but also vascular endothelial and myeloid lineages, it is possible that
proliferation defects are not restricted to the endocardial lineage. How-
ever, these results argue that Hh signaling promotes proliferation of Tg
(etsrp:EGFP)-expressing cells in the ALPM region that include the endo-
cardial progenitors.
To determine if CyA treatment results in increased apoptosis of
endocardial progenitors, anti caspase staining was performed in the
control and CyA-treated Tg(etsrp:EGFP) embryos at the 14–15-somite
stages. No statistically signiﬁcant difference in the numbers of apoptotic
Tg(etsrp:EGFP)-positive cells within the MOC region was observed
(Suppl. Fig. S8).
Notochord is required for endocardial differentiation
Shh expression is observed in the notochord and the ﬂoorplate,
while twhh expression is observed in the hypochord during the somi-
togenesis stages (Ekker et al., 1995; Krauss et al., 1993). In addition,
shh expression has been observed in the endoderm at 26 hpf and
later stages (Reichenbach et al., 2008). Therefore the notochord/ﬂoor-
plate and the endoderm are the two likely sources of the Hh signal.
Floating head (ﬂh) mutants display strong reduction in the number
of notochordal cells and strong downregulation of notochordal and
ﬂoorplate shh expression (Strahle et al., 1996; Talbot et al., 1995).
To determine if the notochord and the ﬂoorplate may be the sources
of the endocardial induction signal, we analyzed endocardial marker
expression in ﬂh mutants. Signiﬁcant reduction in fn1, kdrl and
NFATc1 expression was observed in ﬂh mutants (Fig. 9, Table S5).
While the numbers of endocardial progenitors were reduced, their
migration and coalescence into the heart tube did not appear signiﬁ-
cantly affected. Flh mutants display only partial reduction of shh ex-
pression in the anterior ﬂoorplate (Talbot et al., 1995), which may
explain incomplete loss of endocardial marker expression. Thus the
notochord/ﬂoorplate have at least partial requirement for the endo-
cardial morphogenesis.
Endoderm is required for endocardial progenitor migration but not
differentiation
It has been previously reported that endodermal mutants such as
sox32 have defective migration of myocardial precursors and displayFig. 9. Endocardial morphogenesis is inhibited in ﬂoating head (ﬂh) mutants. (A–D) The nu
notochord deﬁcient ﬂh−/− mutant embryos as compared to their phenotypically normal
24hpf (E,F) and 32 hpf (G,H) stages. In all panels, ventral view of ﬂat-mounted embryos, ansplit myocardial ﬁelds however their differentiation appears unaffected
(Alexander et al., 1999; Kupperman et al., 2000). While it has been ob-
served that endocardial precursors do not migrate to themidline in the
absence of endoderm (Holtzman et al., 2007), their differentiation sta-
tus has not been previously examined. To knockdown sox32 function,
we used a previously validated sox32 MO which results in the nearly
complete absence of the endoderm (Dickmeis et al., 2001). Bilateral
fn1 expression within the presumptive endocardial progenitors was
not affected in sox32 morphants at the 12-somite stage (Figs. 10A,B,
Table S11). However, fn1-expressing endocardial progenitors failed to
migrate towards the midline and remained localized bilaterally at the
later somitogenesis stages (Figs. 10C,D). Similarly, endocardial/
endothelial kdrl and cmlc2 expression remained split bilaterally
(Figs. 10E–H,K,L, Table S11), as previously reported (Holtzman et al.,
2007). Interestingly, sox32 morphants display bilaterally split NFATc1
expression at 26 hpf (Figs. 10I,J). These results argue that migration of
endocardial progenitors towards the midline is not required for their
differentiation and that the two steps in endocardial morphogenesis
are independently regulated. These results also show that the endo-
derm is required for themigration of endocardial progenitors but is dis-
pensable for their differentiation.
Smo function is required cell-autonomouslywithin endocardial progenitors
To test if Hh signaling is received cell-autonomously by the endo-
cardial progenitors, mosaic analysis was performed using smo MO-
injected embryos. Smo morphants display strong reduction in endo-
cardial differentiation and NFATc1 expression. Approximately
50–100 cells from each embryo were transplanted at the sphere
stage from smo MO-injected Tg(ﬂi1a:EGFP)y1 transgenic embryos
into wt recipients. To control for the effectiveness of transplantation,
smo MO solution also contained TRITC-dextran. The recipient embryos
were analyzed at 30–32 hpf for the presence of ﬂi1a:GFP cells. Although
ﬂi1a is expressed in both vascular endothelial and endocardial cells, en-
docardial ﬂi1a expression can be easily recognized by their location
within the beating heart. Because only donor embryos are transgenic
for Tg(ﬂi1a:EGFP), any GFP cells present in the endocardium would be
also defective in smo function. At the same time, control Tg(ﬂi1a:
EGFP) embryos were injected with the same concentration of control
MO and TRITC-dextran mixture, and similar numbers of cells were
transplanted into wt embryos. Averaged from 11 independent experi-
ments, 7.1% of control embryos and 3.1% of smo MO transplantsmber of endocardial fn1 (A,B) and kdrl (C,D) -expressing precursors is reduced in the
siblings at the 18-somite stage. (E–H) NFATc1 expression is reduced in ﬂh mutants at
terior is to the top.
Fig. 11. Donor cells from smoMO-injected Tg(ﬂi1a:EGFP) embryos contribute to vascu-
lar endothelial but not endocardial lineage. Cells were transplanted from smo MO or
control MO-injected Tg(ﬂi1a:EGFP) embryos into wt recipients. Overlap of bright
ﬁeld and green channels, anterior is to the left, embryos are at 32 hpf. (A,B) Endocardial
cells from Tg(ﬂi1a:EGFP) control donor embryos (arrows, A) contribute at a greater fre-
quency to the endocardium of wt recipient embryos compared to the cells from smo
MO donors (B). Note that while two ﬂuorescent cells are shown in (A), the majority
of recipient embryos that showed any contribution of Tg(ﬂi1a:EGFP) cells to the endo-
cardium, displayed only a single GFP-positive cell. (C,D) Transplanted cells from both
control and smo morphants contribute to vascular endothelium (arrows).
Fig. 10. Sox32 function is required for the migration but not differentiation of endocardial precursors. (A–D) Fn1 expression in the endocardial precursors is not affected in the
endoderm-deﬁcient sox32 knockdown embryos at the 12-somite stage (A,B) while they fail to migrate towards the midline at the 16-somite stage (C,D). (E,F) Endocardial kdrl ex-
pression is absent from the midline in sox32morphants at the 18-somite stage. (G–L) Myocardial cmlc2 (G,H,K,L) and endocardial NFATc1 expression (I,J) is split bilaterally in sox32
morphants at the 20-somite (G,H) and 26 hpf stages (I-L). Ventral view of ﬂat-mounted embryos, anterior is to the top in all panels.
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shows that smomorphant cells contribute to the endocardium at a sig-
niﬁcantly lower rate than the control cells (p=0.036). Among the em-
bryos that had any Tg(ﬂi1a:EGFP) cells within the endocardium, the
majority of them (95% of control and 92% of smo morphant embryos)
contained only a single GFP-positive cell (Table S12). Importantly,
there was no reduction in the contribution of smoMO cells to vascular
endothelium; 73.8% of control embryos and 77.8% of smo MO trans-
plants displayed endothelial expression. These results argue that smo
morphant cells can successfully contribute to vascular endothelial but
not endocardial lineage which indicates that Smo function is required
cell-autonomously within the endocardial progenitors.
Discussion
In this study, we show that Hh signaling is required for the earliest
steps of speciﬁcation and differentiation of the endocardial progeni-
tors in a zebraﬁsh embryo. In addition, Hh signaling promotes prolif-
eration of early endocardial progenitors. Furthermore, we show that
Hh signaling is received cell autonomously by the endocardial pro-
genitors, and the notochord is a likely source of Hh signal while the
endoderm is necessary for endocardial migration but is dispensable
for endocardial differentiation.
Hh role in endocardial proliferation, speciﬁcation and differentiation
Because fn1 is the earliest marker associated with endocardial de-
velopment, initiation of its expression may represent endocardial
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Hh-inhibition phenotype such as the absence of NFATc1 expression.
However, ﬂi1+ and kdrl+cells that presumably represent endocardi-
al precursors still migrate to the midline in nat/fn1−/− embryos
(Garavito-Aguilar et al., 2010). Therefore the absence of fn1 expres-
sion alone is insufﬁcient to explain endocardial migration defects ob-
served in Hh-inhibited embryos. It is possible that Hh serves merely
as a permissive factor and induces expression of additional genes
within the endocardial progenitors required for their migration.
However, we cannot exclude a possibility that Hh serves as a che-
moattractant itself for the endocardial progenitor migration. Further-
more, our results suggest that Hh requirement for endocardial
differentiation is separate from its role in endocardial speciﬁcation.
In support to this argument, CyA-treated embryos display endocardial
Tg(etsrp:EGFP) by 48 hpf while NFATc1 expression is mostly absent.
These results suggest that Hh signaling is independently required for
endocardial progenitor speciﬁcation and differentiation.
Our results show that proliferation of Tg(etsrp:EGFP)-positive cells
which include endocardial progenitors, is signiﬁcantly reduced in Hh-
inhibited embryos. Hh is a known mitogen and cell survival factor
(Ingham and McMahon, 2001). Its downstream targets include cell
cycle regulators such as cyclins D1, E and n-myc (Kenney and
Rowitch, 2000; Oliver et al., 2003). Hh signaling has been previously
implicated in the proliferation of the secondary heart ﬁeld progeni-
tors in chick embryos (Dyer and Kirby, 2009). An important question
is whether the defects in endocardial speciﬁcation and differentiation
observed in Hh-inhibited embryos, are merely a consequence of inhi-
bition of endocardial proliferation. If endocardium originates from a
small pool of progenitors that subsequently undergo proliferation,
then inhibition of proliferation would result in greatly reduced num-
bers of differentiated endocardial cells. However, our results argue
against such model. During cell transplantation experiments using
Tg(ﬂi1a:GFP)-positive cells derived from control embryos, among
the transplanted embryos that showed any Tg(ﬂi1a:GFP)-positive
cells within the endocardium, the majority of them contained only a
single GFP-labeled cell. If the endocardium was derived from a small
pool of proliferating progenitors, then the majority of GFP-positive
embryos would contain multiple GFP-positive cells within the endo-
cardium. This suggests that there is very little if any proliferation
among the endocardial progenitors after the speciﬁcation stage until
the time of analysis (32 hpf). One likely explanation for these results
is that Tg(etsrp:EGFP) progenitors proliferate within the MOC region
prior to the endocardial speciﬁcation. Only some of the Tg(etsrp:
EGFP) progenitors will commit to the endocardial fate, mostly after
proliferation is complete while other cells may contribute to the vas-
cular endothelial and/or myeloid lineages. Therefore if transplanted
cells become localized to the MOC region and proliferate, only a frac-
tion of their progenitors will contribute to the endocardium. Hh-
inhibited embryos then display reduced proliferation of Tg(etsrp:
EGFP) progenitors prior to their commitment to the endocardial line-
age. Our data also cannot exclude the possibility that while most en-
docardial progenitors do not proliferate after endocardial
speciﬁcation, there is a small pool of highly proliferative progenitors
which may be difﬁcult to target in transplantation experiments but
which may account for a signiﬁcant portion of the endocardial
growth.
Requirement for Hh signaling in endocardial andmyocardialmorphogenesis
Interestingly, although endocardial and vascular endothelial cells
share expression of multiple markers and may originate from a
common precursor, endocardial development is not affected by
Vegf and Notch signals that regulate endothelial differentiation. In-
stead, based on our and previous studies, both endocardial and
myocardial progenitors require Hh signal for proper morphogenesis
(Thomas et al., 2008). It has been shown previously that both BMPand Wnt signals are also similarly required for endocardial and
myocardial differentiation in vitro (Misfeldt et al., 2009). Therefore
it appears that similar signals may induce speciﬁcation of both en-
docardial and myocardial lineages. Since both myocardial and endo-
cardial progenitors develop in close vicinity, an important question
is whether Hh signaling is directly received by the endocardial pro-
genitors or whether endocardial defects in Hh-inhibited embryos
can be indirect consequence of inhibited myocardial morphogene-
sis. Several lines of evidence argue that Hh role in endocardial mor-
phogenesis is independent from its myocardial role. Hedgehog
affects fn1 expression in endocardial progenitors as early as the
10-somite stage, when endocardial progenitors are positioned
more rostrally to the myocardial cells within the ALPM and the ma-
jority of endocardial and myocardial cells are not in direct contact.
Second, the time interval of Hh requirement for endocardial mor-
phogenesis, between the tailbud and the 15-somite stages, is differ-
ent from its previously established requirement in myocardial
morphogenesis, between the germ ring and the 10-somite stage
(Thomas et al., 2008). As we show in the current study, embryos
treated with CyA at the 15-somite stage, show only defects in endo-
cardial but not myocardial morphogenesis. And ﬁnally, mosaic analysis
using Smomorphants argues thatHh signal is receiveddirectlywithin en-
docardial progenitors. Therefore Hh signaling appears to have two inde-
pendent roles in endocardial and myocardial development.
Potential sources of Hh signaling
Knockdown of shh alone has only minor effect on endocardial for-
mation, while simultaneous knockdown of shh and twhh results in the
nearly complete absence of endocardial markers. This argues that Shh
and Twhh function redundantly during endocardial morphogenesis.
The potential sources for Hh signal are the notochord, ﬂoorplate and
the hypochord where Shh and Twhh expression is observed, and
the endoderm (Ekker et al., 1995; Krauss et al., 1993; Reichenbach
et al., 2008). Although endodermal Hh expression has not been ob-
served prior to 26 hpf, low amounts of Hh cannot be excluded. Flh
mutants display nearly complete loss of notochordal cells and strong-
ly reduced or lost shh and twhh expression in the notochord and the
ﬂoorplate (Du and Dienhart, 2001; Strahle et al., 1996; Talbot et al.,
1995). Flh mutants display signiﬁcant reduction in the endocardial
marker expression which supports the hypothesis that notochordal
and ﬂoorplate-derived Shh and Twhh induce endocardial differentia-
tion. Although signiﬁcant NFATc1 expression is still present in ﬂhmu-
tants this can be explained by only mild reduction in shh expression
within the anterior neural plate observed in ﬂh mutants (Talbot et
al., 1995). Alternatively, there could be another source of Hh signal.
Importantly, the endoderm is required for migration but dispensable
for differentiation of endocardial progenitors, similar to its require-
ment in migration of myocardial progenitors. These ﬁndings argue
that endocardial progenitor migration and differentiation are regulated
independently.
Evolutionary conservancy of Hh and Vegf signaling
An important question is whether the mechanisms of endocardial
speciﬁcation and requirement for Hh signaling are evolutionarily con-
served between zebraﬁsh and mammalian embryos. Fate mapping
experiments in avian and zebraﬁsh embryos have argued that endo-
cardial and myocardial populations separate during early gastrulation
stages, and a single labeled progenitor gave rise to either endocardial
or myocardial cells but never both (Cohen-Gould and Mikawa, 1996;
Lee et al., 1994; Milgrom-Hoffman et al., 2011; Wei and Mikawa,
2000). In contrast, Cre-based fate mapping approaches in mouse em-
bryos showed that the progeny of labeled cells was observed in both
endocardial and myocardial lineages (Cai et al., 2003; Verzi et al.,
2005), although recent data suggest that mammalian endocardium
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not share a common origin with myocardial progenitors (Milgrom-
Hoffman et al., 2011). In vitro studies have shown that the progeny
of a single ﬂk1+cardiovascular progenitor can contribute tomyocardial
and vascular endothelial/endocardial lineages (Kattman et al., 2006;
Misfeldt et al., 2009). It is possible that zebraﬁsh cardiovascular lineages
develop differently frommammalian and the common myocardial–en-
docardial progenitors exist only in mammalian and not zebraﬁsh or
avian development. However, no single cell fate mapping has been per-
formed in mammalian embryos so far. Therefore, it is possible that Cre-
reporters independentlymark two distinct cell populations which orig-
inate from distinct progenitors (Harris and Black, 2010). Recent studies
show that both zebraﬁsh and mouse endothelial–endocardial cells re-
tain developmental plasticity and can be reprogrammed intomyocardi-
al cells in the absence of Etsrp/Etv2 function (Palencia-Desai et al., 2011;
Rasmussen et al., 2011; Schoenebeck et al., 2007). It is quite plausible
that in both zebraﬁsh and mammalian embryos endocardial and myo-
cardial cells are derived frommultipotent progenitors which retain de-
velopmental plasticity for a prolonged time. However, during normal
development, these endocardial and myocardial progenitors are spa-
tially separated and are derived from distinct subpopulations of these
progenitors.
Previous studies have implicated Hh signaling in myocardial de-
velopment both in mammalian and ﬁsh embryos. Thus myocardial-
speciﬁc markers are downregulated in Smo−/− knockdown mice
and Hh-inhibited zebraﬁsh embryos (Thomas et al., 2008; Zhang et
al., 2001). This suggests that the role of Hh signaling in cardiac devel-
opment may be evolutionarily conserved. While it appears that endo-
cardium may be present in mouse Smo−/− or Shh/Ihh−/− mutant
embryos, endocardial differentiation in these embryos has not been pre-
viously analyzed in greater detail, to our knowledge. Our results show
that zebraﬁsh Hh-inhibited embryos, similar to mouse Smo−/− or
Shh/Ihh−/− embryos, do form dysmorphic endocardium at later stages,
however, nfatc1 expression is greatly downregulated. Evolutionary
conservancy for this Hh requirement still needs to be tested in future
experiments.
Mouse VegfA and Flk1 knockout embryos show early defects of
yolk sac vasculogenesis (Carmeliet et al., 2009; Ferrara et al., 1996;
Shalaby et al., 1995). Tie2Cre; Flk1 null mouse mutants lack both en-
dothelial and endocardial cells which argues that Vegf-Flk1 signaling
is required for both endothelial and endocardial development
(Milgrom-Hoffman et al., 2011). However, because overall early en-
dothelial development is defective, it is hard to determine if VegfA
has a speciﬁc requirement in early endocardial morphogenesis. Inter-
estingly, hypomorphic VegfA knock-in allele shows no apparent de-
fects in endocardial morphogenesis while blood vessel formation is
greatly abnormal (Damert et al., 2002). Similarly, our results suggest
that zebraﬁsh VegfA knockdown embryos do not show major defects
in early endocardial morphogenesis while they display defects in vas-
cular development. It is quite possible that VegfA MO knockdown
cannot fully eliminate Vegf function, therefore this phenotype is
hypomorphic and appears very similar to the mouse hypomorphic
phenotype. In addition, VegfA in zebraﬁsh may function redundantly
with other Vegf homologs such as VegfAb and VegfC. Therefore our
results cannot fully exclude requirement for Vegf signaling during
early endocardial morphogenesis and suggest that the role for both
Vegf signaling may not be that different between mammalian and
zebraﬁsh embryos.
In summary, our study identiﬁes Hh as a key signaling pathway
which is involved in the speciﬁcation and differentiation of zebraﬁsh
endocardial progenitors. Cardiac morphogenesis and differentiation,
including the endocardial NFATc1 expression pattern are highly con-
served between zebraﬁsh andmammalian embryos. Therefore our re-
sults will be important for understanding molecular mechanisms of
cardiac morphogenesis which are related to multiple congenital
heart defects in humans.Supplementary materials related to this article can be found on-
line at doi:10.1016/j.ydbio.2011.11.004.
Supplementary data to this article can be found online at doi:10.
1016/j.ydbio.2011.11.004.Acknowledgments
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